Left main session

• Clinical trials strongly support overall no differences in death or MI, possibly lower stroke but higher TLR with PCI and these outcomes are durable over time
• SYNTAX Trial does encourage expansion of PCI strategy to Low SYNTAX Score patients
• Beside SYNTAX Score Simple Risk models can help decision making for PCI vs CABG ( i.e. ACEF )
• Role for IVUS and FFR as diagnostic and guidance tools
• ‘Heart Team’ approach for PCI and CABG is recommend in overlapping subgroups with LM disease for an optimal clinical practice